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I
n the developing world the approval and cultivation of geneti-
cally modified (GM) crops is largely limited to the commercial
production of insect-resistant cotton in Argentina,China,India,
Mexico,and South Africa. Approvals of GM crops used for food
or feed lag far behind cotton:a single transgenic maize event (an
instance of genetic modification) has been approved in the
Philippines and South Africa,and a single transgenic soybean
event has been approved in Argentina,Mexico,South Africa,and
Uruguay.Argentina has also approved six GM corn events for
cultivation. In contrast,11 food and feed crops representing
over 47 transgenic events have been approved for cultivation in
the developed world.
This gap in approvals is unfortunate,because crop biotech-
nology,appropriately applied,has the potential to address key
production constraints affecting resource-poor farmers.
Currently,important public- and private-sector research is
underway to help meet the productivity needs of these farmers.
This research is built on the transformation of local crop
germplasm and the expression of locally important traits.The
work involves national research programs in developing coun-
tries and international centers.To date,over 50 crops have been
transformed in 16 developing countries,incorporating a wide
range of genes for insect,fungal,viral,and bacteria resistance;
protein and quality improvements;herbicide tolerance;and salt
and drought stress.
However, the value of these novel crops will be realized
only after they are approved for cultivation by national regula-
tory authorities. Obtaining environmental and food safety
approval is difficult though, given current institutional capacities,
technological capabilities, and political decisions regarding regu-
lation in developing countries. In fact, the approval process,
while addressing safety concerns, can also be a significant con-
straint to introducing GM seeds in the developing world. Many
countries, such as Zambia and Zimbabwe, also maintain GM-
free policies to certify and protect domestic food markets and
beef exports to Europe.
Over and above having to increase regulatory capacity,
developing countries face competing regulatory paradigms in the
developed world.Although governments have reached relatively
clear agreement on the scientific principles of food safety assess-
ment,they have not reached consensus on the extent of data
required to comply with these principles or on the role of data
in overall decisionmaking.As a result,developing countries face
the following questions:What information will assure developed
countries that they are importing safe food? How and by whom
should this information be generated? And how should it be
shared for maximum advantage? Furthermore,developing coun-
tries will have to assess how their exports will be affected if
developed countries require labeling of GM foods.In approving
GM crops,developing countries evaluate not only how GM
seeds impact agricultural productivity,but also how GM prod-
ucts influence their participation in global trade.
FOOD SAFETY IN GM CROPS
Plant breeders have continuously introduced new crops,genes,
and traits into our diet and farming communities with few food
and feed safety problems. We know,however,that some tradi-
tionally developed foods that contain allergenic proteins can
cause mild to severe reactions from milk,shellfish,soya,peanuts,
wheat,tree nuts,and eggs. Furthermore,traditional breeding of
products such as potatoes can cause elevated amounts of
endogenous toxicants such as glycoalkaloids. By comparison,no
approved biotechnology product has been found to produce
allergic or toxic reactions.
However,concerns with genetically engineered crops persist
partially because of the perception that gaining access to a wider
range of genetic diversity,crossing species barriers,and introduc-
ing foods with additional proteins present safety concerns via
our diets.The main source of worry is the potential for allergic
reactions.One example of allergenic concerns arose in the sum-
mer of 2000,when traces of StarLink™ corn were detected in
some food products,such as taco shells.StarLink™ was
approved for use in animal feed,but not for human consump-
tion.Approval for human consumption was withheld because the
Bt Cry9c protein in corn did not disappear as quickly as other
Bt proteins in test assays.The unintentional commingling of
StarLink™ with corn in the food chain led to concerns about
food safety.The U.S.Food and Drug Administration (FDA) devel-
oped a method to detect the antibody indicating hypersensitivity
to the Cry9c protein.The FDA evaluated the actual case sam-
ples against reference samples.It sent the data to the Centers
for Disease Control,which compared case values with control
values.These studies found no allergenic reactions associated
with Cry9c.
REGULATORY APPROACHES TO FOOD SAFETY
FOR GM FOODS
The Organisation for Economic Co-operation and Development
(OECD) defines food safety as “reasonable certainty that no
harm will result from intended uses under anticipated conditions
of consumption.” To arrive at reasonable certainty,the OECD
uses the concept of substantial equivalence (as developed by the
World Health Organization,the OECD,and the Food and
Agriculture Organization of the United Nations),because con-
ventional toxicology cannot adequately evaluate novel foods.
Substantial equivalence “embodies the idea that existing organ-
isms used as food,or as a source of food,can be used as the
basis for comparison when assessing the safety of human con-
sumption of a food or food component that has been modified
or is new.” The concept also serves as the premise for workbased on the Codex Alimentarius, which has become the semi-
nal global reference point for consumers, food producers and
processors, national food control agencies, and international
food trade.
Substantial equivalence offers a science-based approach for
comparing genetically modified foods with an existing or con-
ventionally bred counterpart. Providing clear analysis of differ-
ences and similarities between these foods can help structure a
safety assessment, but by itself, substantial equivalence is not a
safety assessment.This concept has been the target of criticism,
as some believe it does not provide enough information to
determine safety.
Data that help determine or explain similarities and differ-
ences between GM and traditional foods come largely from
molecular and protein characterization, which, some propose,
can involve testing to determine gene expression patterns, pro-
tein profiling, changes in protein expression, and differences in
metabolic capabilities. One difficulty in utilizing this information
is that the biological significance and safety implications of the
data may not be established.
The application of characterization and feeding methodolo-
gies also presents problems. Standards used in the U.S. or
Europe to determine food safety present significant difficulties
in the developing world. Even though food safety data generat-
ed by one country can be submitted and accepted in another,
countries may not be aware of data generated elsewhere.
Countries may also seek additional feeding trials or molecular
studies over and above commonly required tests. If generation
of additional data requires sophisticated technologies, as is the
case for protein profiling, then developing countries will be
strained to comply with food safety standards. Developing
countries themselves have called for additional animal feeding
studies, to assure those concerned about the safety of animals
that may consume GM products in the field.
Food safety assessments are essential to GM approvals and,
as such,need to be started early in the process of GM crop
development.Commercial providers of GM crops often com-
plete food safety assessments with seed or other material har-
vested from confined trials (that is,before committing to exten-
sive seed production).For developing countries,such a sequence
in GM crop development may be problematic,because they may
have few laboratories and scientists capable of food safety test-
ing,may lack information on the tests or data required,and may
not have fully anticipated funding needs. In addition,it is often
difficult to obtain approval for multilocation,confined field trials,
and yet these trials are needed by scientists to obtain material
for safety evaluations.For these reasons,food safety testing,
including generation of data and regulatory review,has become
one of several problematic issues in the regulation of GM crops.
While the proponent of a given GM event is expected to
test for safety (rather than a regulatory agency), a competent
regulatory authority needs to review the data. However, it is for
each developing country to determine how, when, and to what
extent regulatory agencies themselves will be involved in test-
ing.The challenge of assuring safety becomes more complicated
as the range of GM products expands and the chance that a
substantial comparator crop exists decreases. Difficulty in
reaching international agreement on food safety standards and
scientific uncertainty about how to evaluate safety, coupled with
the lack of a clear,“one-window” approach for regulation in
developing countries, means that developed and developing
countries lack a clear, uniformly accepted path to regulatory
approval of GM foods.
WHAT DOES THE FUTURE HOLD?  
It is often stated that GM products pose no new food safety
risks when compared to traditionally produced foods, and to
date, no safety problems have been identified for GM products
approved for use. Most GM products are considered substan-
tially equivalent to traditional counterparts, with exceptions for
certain well-defined differences. Safety evaluations focus on
these defined differences. For developing countries, the need to
make such assessments raises questions about who will gener-
ate the data; which approach will be followed (substantial equiv-
alence or some other); and what degree of uncertainty about
food safety developing countries will permit?  
The present atmosphere surrounding genetically engi-
neered crops has led to a situation where food safety assess-
ment is not just about science, but also about perceptions, con-
cerns, and standards about how to assure “safety.” As scientific
opportunities advance, agreement on reasonable standards of
safety for developing countries will be critical.This will also
allow for and encourage exchange of data, which will help
ensure that data requirements are manageable not only among
OECD countries, but across the developing world as well.As
part of capacity building for biotechnology and biosafety, com-
petency in assuring food safety for GM crops is essential.This
competency will enable countries to conduct independent
research when necessary. Building such capacity also creates
sufficient infrastructure to allow scientifically defensible deci-
sions in the face of food safety questions colored by each coun-
try’s perceptions and circumstances. ■
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